UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in AGIO — Agios Pharmaceuticals, Inc.
CIK 861177
NEW YORK, NY
Position in AGIO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,744,265
+$831,839 QoQ
Shares Held
110,679
+3.4% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 47%
Shared 0%
None 53%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,605,811 across 211 Biotechnology names. AGIO ranks #78 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in AGIO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,744,265 | 110,679 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,912,426 | 106,996 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,289,960 | 106,875 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,230,787 | 217,402 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,315,183 | 147,276 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $4,036,355 | 122,835 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,030,761 | 113,229 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,410,264 | 125,470 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,387,757 | 47,461 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,056,954 | 47,461 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,174,658 | 47,461 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,095,121 | 250,534 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,754,763 | 250,534 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $11,437,235 | 407,309 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $12,990,275 | 459,345 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,553,206 | 476,013 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,883,444 | 64,701 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,126,719 | 64,701 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,056,372 | 66,227 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,984,119 | 72,294 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $4,923,097 | 95,335 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $3,969,718 | 91,616 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $2,677,325 | 76,495 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,177,854 | 78,120 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $15,959,859 | 449,827 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||